Shin Nippon Biomedical Laboratories Ltd
TSE:2395
Shin Nippon Biomedical Laboratories Ltd
Capital Expenditures
Shin Nippon Biomedical Laboratories Ltd
Capital Expenditures Peer Comparison
Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
Shin Nippon Biomedical Laboratories Ltd
TSE:2395
|
Capital Expenditures
-¥8.6B
|
CAGR 3-Years
-97%
|
CAGR 5-Years
-51%
|
CAGR 10-Years
-17%
|
CMIC Holdings Co Ltd
TSE:2309
|
Capital Expenditures
-¥6.2B
|
CAGR 3-Years
10%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-6%
|
|
Medinet Co Ltd
TSE:2370
|
Capital Expenditures
-¥77.1m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
12%
|
CAGR 10-Years
5%
|
|
CellSource Co Ltd
TSE:4880
|
Capital Expenditures
-¥359m
|
CAGR 3-Years
-122%
|
CAGR 5-Years
-71%
|
CAGR 10-Years
N/A
|
|
Linical Co Ltd
TSE:2183
|
Capital Expenditures
-¥6.5m
|
CAGR 3-Years
54%
|
CAGR 5-Years
37%
|
CAGR 10-Years
5%
|
|
WDB coco Co Ltd
TSE:7079
|
Capital Expenditures
-¥87.2m
|
CAGR 3-Years
-250%
|
CAGR 5-Years
-171%
|
CAGR 10-Years
N/A
|
See Also
What is Shin Nippon Biomedical Laboratories Ltd's Capital Expenditures?
Capital Expenditures
-8.6B
JPY
Based on the financial report for Mar 31, 2024, Shin Nippon Biomedical Laboratories Ltd's Capital Expenditures amounts to -8.6B JPY.
What is Shin Nippon Biomedical Laboratories Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-17%
Over the last year, the Capital Expenditures growth was -74%. The average annual Capital Expenditures growth rates for Shin Nippon Biomedical Laboratories Ltd have been -97% over the past three years , -51% over the past five years , and -17% over the past ten years .